Vericel (VCEL) Tax Provisions (2020 - 2024)
Vericel (VCEL) posted Tax Provisions of $148000.0 for Q4 2024, down 86.55% sequentially from $1.1 million in Q4 2023, and down 86.55% YoY from $1.1 million in Q1 2024.
Analysis
Vericel (VCEL) Tax Provisions (2020 - 2024) Analysis & Trends
Vericel has reported Tax Provisions for 5 years, with the latest figure at $148000.0 in Q4 2024.
- Quarterly Tax Provisions fell 86.55% year-over-year to $148000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $962000.0 (down 37.33% YoY) and the FY2025 annual result came in at $859000.0, up 480.41% from the prior year.
- Tax Provisions fell to $148000.0 in Q4 2024 per VCEL's latest filing, from $1.1 million in the prior quarter.
- Over five years, Tax Provisions peaked at $1.1 million in Q4 2023 and troughed at -$326000.0 in Q4 2021.
- A 5-year average of $194666.7 and a median of $143000.0 in 2021 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions soared 314.72% in 2022, then slumped 1461.9% in 2023.
- Over 5 years, Tax Provisions stood at $180000.0 in 2020, then slumped by 281.11% to -$326000.0 in 2021, then jumped by 314.72% to $700000.0 in 2022, then jumped by 57.14% to $1.1 million in 2023, then sank by 86.55% to $148000.0 in 2024.
- According to Business Quant data, Tax Provisions over the past three periods registered $148000.0, $1.1 million, and -$286000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -286,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Dec 31, 2021 | -326,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 143,000.00 |
| Dec 31, 2020 | 180,000.00 |